Skip to main content
Article thumbnail
Location of Repository

A Kinetic Insight into Troponin T Mutations Related To Dilated and Hypertrophic Cardiomyopathies

By Fatima Zimna Wazeer


Dilated and Hypertrophic Cadiomyopathy can be caused by mutations of genes encoding sarcomeric proteins. Mutations in cTnT are of particular interest since they are generally associated with mild or no ventricular hypertrophy but a high incidence of sudden death. Previous investigations have focused on steady state parameters such as maximal activation and inhibition of actomyosin ATPase and force and Ca2+ sensitivity. We have aimed to use transient kinetics to investigate the effects of 7 cTnT mutations on the dynamics of thin filament switching. We have studied two DCM mutations (R141W, ∆K210) and five HCM (∆E160, S179F, K273E, ∆14, ∆28+7) mutations present in two functional domains of TnT (T1 and T2). \ud Overall circular dichroism studies showed that the structure of these mutant proteins is not grossly affected although minor changes in the α–helical content were found for cTnT mutants K273E, ∆14, ∆28+7 and ∆E160. Co-sedimentation with actin suggested that most of cTnT mutations do not interfere with the association between cTn and thin filament except for the truncated mutations. \ud Cooperativity along thin filament was changed for all deletion mutations (∆K210, ∆E160, ∆14 and ∆28+7) but unchanged by the point mutations. In this study we also demonstrated that the equilibrium constant between the blocked and closed states (KB) for DCM mutations were unchanged but increased dramatically for HCM mutations suggesting loss of blocked state specifically for those in the T2 region. \ud We assessed Ca2+ binding of the regulatory site of cardiac TnC using IAANS attached to C35 and C84 of cTnC. Ca2+ binding affinity (pCa50 =6.65) of reconstituted Tn complex was unaffected by all mutations with the exception of ∆28+7 which caused a decrease (pCa50 0.34). In contrast when incorporated into thin filament, all HCM mutations and DCM ∆K210 showed increased Ca2+ affinity. The observed rate constant of Ca2+ dissociation was unchanged for all mutations except for ∆28+7. \ud In conclusion, we have observed multiple structural and functional consequences from different TnT mutations that occur in different regions of the molecule. Overall the data suggests that it is the functional changes caused by mutations that are critical in developing the disease and not the specific location of the mutation

Publisher: University of Leicester
Year: 2011
OAI identifier:

Suggested articles


  1. (1995). A direct regulatory role for troponin T and a dual role for troponin C in the Ca2+ regulation of muscle contraction."
  2. (1993). A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2."
  3. (1997). A kinetic model for the binding of Ca2+ to the regulatory site of troponin from cardiac muscle."
  4. (1953). A microscopic method for the determination of inorganic phosphorus."
  5. (1990). A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation."
  6. (1996). A mouse model of familial hypertrophic cardiomyopathy."
  7. (1998). A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity."
  8. (1998). A new look at thin filament regulation in vertebrate skeletal muscle."
  9. (1999). A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy."
  10. (2002). A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy."
  11. (1998). A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy."
  12. (2001). Abnormal contractile function in transgenic mice expressing a familial hypertrophic cardiomyopathylinked troponin T (I79N) mutation."
  13. (1978). Actin mediated release of ATP from a myosin-ATP complex."
  14. (1998). Actin mutations in dilated cardiomyopathy, a heritable form of heart failure."
  15. (1997). Actin-tropomyosin activation of myosin subfragment 1 ATPase and thin filament cooperativity. The role of tropomyosin flexibility and end-to-end interactions."
  16. (1990). Actin."
  17. (1994). Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere."
  18. (1999). Alphacardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy."
  19. (1992). Alteration of contractile function and excitation-contraction coupling in dialted cardiomyopathy."
  20. (2002). Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy."
  21. (2000). Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy."
  22. Amino-acid sequence of tropomyosin-binding component of rabbit skeletal muscle troponin."
  23. (1992). Analysis of troponin-tropomyosin binding to actin. Troponin does not promote interactions between tropomyosin molecules."
  24. (2000). Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy."
  25. (1958). Asymmetrical hypertrophy of the heart in young adults."
  26. (1990). Atomic model of the actin filament."
  27. (1990). Atomic structure of actin:DNase I complex."
  28. (1990). Binding of a calcium sensitizer, bepridil, to cardiac troponin C. A fluorescence stopped-flow kinetic, circular dichroism, and proton nuclear magnetic resonance study."
  29. (1996). Bisphosphorylation of cardiac troponin I modulates the Ca(2+)-dependent binding of myosin subfragment S1 to reconstituted thin filaments."
  30. (2001). Ca(2+) activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T."
  31. (2002). Ca(2+)-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy."
  32. (2005). Ca(2+)-regulated structural changes in troponin."
  33. (1992). Ca2+ regulation of mechanical properties of striated muscle. Mechanistic studies using extraction and replacement of regulatory proteins."
  34. (1999). Ca2+ sensitization and potentiation of the maximum level of myofibrillar ATPase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy."
  35. (1998). Ca2+-sensitizing effects of the mutations at Ile-79 and Arg-92 of troponin T in hypertrophic cardiomyopathy."
  36. (1995). Calcium binding to the regulatory N-domain of skeletal muscle troponin C occurs in a stepwise manner."
  37. (2008). Calcium cycling and signaling in cardiac myocytes."
  38. (1996). Calcium regulation of thin filament movement in an in vitro motility assay."
  39. (2007). Calcium regulation of troponin and its role in the dynamics of contraction and relaxation."
  40. (1987). Calcium-binding properties of troponin C in detergent-skinned heart muscle fibers."
  41. (2005). Calcium, thin filaments, and the integrative biology of cardiac contractility."
  42. (2000). Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling."
  43. (2008). Cardiac thin filament regulation."
  44. (2008). Cardiac troponin I gene mutation (Asp127Tyr) in a Chinese patient with hypertrophic cardiomyopathy]."
  45. (2005). Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences."
  46. (2003). Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca2+ desensitization."
  47. (2008). Cardiac troponin T mutations promote lifethreatening arrhythmias."
  48. (1999). Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy."
  49. (2001). Cardiac troponin T mutations: correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice."
  50. (2001). Cardiomyopathies: from genetics to the prospect of treatment."
  51. (2010). Cardiomyopathy-causing deletion K210 in cardiac troponin T alters phosphorylation propensity of sarcomeric proteins."
  52. (1995). Characterisation of the equilibrium between blocked and closed states of muscle thin filaments."
  53. (1999). Characterization of the cardiac holotroponin complex reconstituted from native cardiac troponin T and recombinant I and C."
  54. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4."
  55. (2008). Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy."
  56. (2003). Comparison of fluorescent SSCP and denaturing HPLC analysis with direct sequencing for mutation screening in hypertrophic cardiomyopathy."
  57. (2007). Computational simulation of hypertrophic cardiomyopathy mutations in troponin I: influence of increased myofilament calcium sensitivity on isometric force, ATPase and [Ca2+]i."
  58. (1996). Contractile protein mutations and heart disease."
  59. (2006). Controversies in ventricular remodelling."
  60. (1999). Cooperativity and switching within the three-state model of muscle regulation."
  61. (2001). Cross-bridge interaction kinetics in rat myocardium are accelerated by strong binding of myosin to the thin filament."
  62. (2001). Crossbridge and tropomyosin positions observed in native, interacting thick and thin filaments."
  63. (2000). Crystal structure of tropomyosin at 7 Angstroms resolution."
  64. (2003). Different functional properties of troponin T mutants that cause dilated cardiomyopathy."
  65. (2008). Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies."
  66. (2003). Differential regulation of the actomyosin interaction by skeletal and cardiac troponin isoforms."
  67. (2007). Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments."
  68. (1999). Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice."
  69. (2005). Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype."
  70. (1978). Direct identification of the high and low affinity calcium binding sites of troponin-C."
  71. (1997). Disparate fluorescence properties of 2-[4'-(iodoacetamido)anilino]-naphthalene-6-sulfonic acid attached to Cys-84 and Cys-35 of troponin C in cardiac muscle troponin."
  72. (1994). Dynamics of the muscle thin filament regulatory switch: the size of the cooperative unit."
  73. (2004). Effects of protein kinase C dependent phosphorylation and a familial hypertrophic cardiomyopathy-related mutation of cardiac troponin I on structural transition of troponin C and myofilament activation."
  74. (2007). Effects of thin and thick filament proteins on calcium binding and exchange with cardiac troponin C."
  75. (1983). Effects of troponin-I plus-C on the binding of troponin-T and its fragments to alpha-tropomyosin. Ca2+ sensitivity and cooperativity."
  76. (2005). Electrical activity of the heart". Cardiovascular physiology concepts . Lippincott Williams & Wilkins.
  77. (1972). Enzyme kinetics and the mechanism of muscle contraction."
  78. et al(1995). "Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy."
  79. (1990). Excimer fluorescence of pyrenyliodoacetamide-labeled tropomyosin: a probe of the state of tropomyosin in reconstituted muscle thin filaments."
  80. (1996). Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action."
  81. (1997). Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility."
  82. (1995). Familial dilated cardiomyopathy in the United Kingdom."
  83. (1999). Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group."
  84. (2004). Familial hypertrophic cardiomyopathy mutations from different functional regions of troponin T result in different effects on the pH and Ca2+ sensitivity of cardiac muscle contraction."
  85. (2003). Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling."
  86. (1998). Familial hypertrophic cardiomyopathy: from mutations to functional defects."
  87. (2001). First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy."
  88. (1987). Fluorescence probe studies of the state of tropomyosin in reconstituted muscle thin filaments."
  89. (2004). Fluorescence resonance energy transfer between points on actin and the C-terminal region of tropomyosin in skeletal muscle thin filaments."
  90. (1997). Fluorescent probes attached to Cys 35 or Cys 84 in cardiac troponin C are differentially sensitive to Ca(2+)-dependent events in vitro and in situ."
  91. (1981). Fluorimetry study of N-(1-pyrenyl)iodoacetamide-labelled F-actin. Local structural change of actin protomer both on polymerization and on binding of heavy meromyosin."
  92. (1998). Frequency and phenotypes of familial dilated cardiomyopathy."
  93. (1998). Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function."
  94. (2009). Functional analysis of a unique troponin c mutation, GLY159ASP, that causes familial dilated cardiomyopathy, studied in explanted heart muscle."
  95. (1999). Functional analysis of human cardiac troponin by the in vitro motility assay: comparison of adult, foetal and failing hearts."
  96. (1999). Functional changes in troponin T by a splice donor site mutation that causes hypertrophic cardiomyopathy."
  97. Functional consequences of a carboxyl terminal missense mutation Arg278Cys in human cardiac troponin T."
  98. (2000). Functional consequences of the deletion mutation deltaGlu160 in human cardiac troponin T."
  99. (1999). Functional consequences of troponin T mutations found in hypertrophic cardiomyopathy."
  100. (1992). Functional delineation of the Ca(2+)-deficient EF-hand in cardiac muscle, with genetically engineered cardiacskeletal chimeric troponin C."
  101. (2005). Gene mutations in adult Japanese patients with dilated cardiomyopathy."
  102. (2000). Homozygous mutation in cardiac troponin T: implications for hypertrophic cardiomyopathy."
  103. (1994). How molecular motors work."
  104. (1995). Human cardiac troponin T: cloning and expression of new isoforms in the normal and failing heart."
  105. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy."
  106. (2003). Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy."
  107. (2001). Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease."
  108. (2003). Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion."
  109. Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy-associated mutant troponin T proteins."
  110. (1980). Identification of a factor in conventional muscle actin preparations which inhibits actin filament selfassociation."
  111. (2003). Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T."
  112. (1995). In vitro motility analysis of actintropomyosin regulation by troponin and calcium. The thin filament is switched as a single cooperative unit."
  113. (2006). Increased Ca2+ affinity of cardiac thin filaments reconstituted with cardiomyopathy-related mutant cardiac troponin I."
  114. Independent FHC-related cardiac troponin T mutations exhibit specific alterations in myocellular contractility and calcium kinetics."
  115. (1992). Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA."
  116. (1987). Isolation and sequence of a cDNA clone for rabbit fast skeletal muscle troponin C. Homology with calmodulin and parvalbumin."
  117. (1985). Kinetic studies of calcium binding to regulatory complexes from skeletal muscle."
  118. (1996). Kinetic studies of calcium binding to the regulatory site of troponin C from cardiac muscle."
  119. (1980). Kinetic studies of the cooperative binding of subfragment 1 to regulated actin."
  120. (1999). Late-onset hypertrophic cardiomyopathy caused by a mutation in the cardiac troponin T gene."
  121. (1994). Length, force, and Ca(2+)-troponin C affinity in cardiac and slow skeletal muscle."
  122. (1983). lntraceUular measurement of ion activities,
  123. (2001). Mapping the interacting regions between troponins T and C. Binding of TnT and TnI peptides to TnC and NMR mapping of the TnT-binding site on TnC."
  124. Modulation of Thin Filament Activity in Long and Short term regulation of Cardiac Function”, Molecular Control Mechanisms in Striated Muscle Contraction, R.J.Solaro, R.L.Moss, eds,
  125. (2004). Molecular and cellular aspects of troponin cardiomyopathies."
  126. (2002). Molecular mechanisms of cardiac myofilament activation: modulation by pH and a troponin T mutant R92Q."
  127. (1997). Molecular polarity in tropomyosin-troponin T co-crystals."
  128. (2002). Mutation analysis of the G4.5 gene in patients with isolated left ventricular noncompaction."
  129. (1996). Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle."
  130. (2005). Mutations in human cardiac troponin I that are associated with restrictive cardiomyopathy affect basal ATPase activity and the calcium sensitivity of force development."
  131. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy."
  132. (1995). Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy."
  133. (1997). Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy."
  134. (1995). Mutations in the genes for cardiac troponin T and alphatropomyosin in hypertrophic cardiomyopathy."
  135. (2002). Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy."
  136. (2001). Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy."
  137. (1996). Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation."
  138. (2008). Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice."
  139. (2004). Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy."
  140. Myosin-induced movement of alphaalpha, alphabeta, and betabeta smooth muscle tropomyosin on actin observed by multisite FRET."
  141. (2004). N terminus is essential for tropomyosin functions: N-terminal modification disrupts stress fiber organization and abolishes anti-oncogenic effects of tropomyosin-1."
  142. (1999). Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene."
  143. (2006). New insights into myosin evolution and classification."
  144. (1995). NMR solution structure of calciumsaturated skeletal muscle troponin C."
  145. (2001). Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy."
  146. (2001). Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome."
  147. (1995). Novel missense mutation in alpha-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy."
  148. (2001). Overexpression of human cardiac troponin in Escherichia coli: its purification and characterization."
  149. (2003). Phenotyping hypertrophy: eschew obfuscation."
  150. (2003). Phosphorylation and mutation of human cardiac troponin I deferentially destabilize the interaction of the functional regions of troponin I with troponin C."
  151. (1982). Preparation of myosin and its subfragments from rabbit skeletal muscle."
  152. (1982). Preparation of troponin and its subunits."
  153. (2003). Prevalence and clinical profile of troponin T mutations among patients with hypertrophic cardiomyopathy in tuscany."
  154. (2000). Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Res 1999;44:20 – 36.Cardiovasc
  155. (2005). Protein kinase cascades in the regulation of cardiac hypertrophy."
  156. (1951). Protein measurements with Folin phenol reagent."
  157. (1988). Refined crystal structure of troponin C from turkey skeletal muscle at 2.0 A resolution."
  158. (2000). Regulation of contraction in striated muscle."
  159. (1993). Regulation of the interaction between actin and myosin subfragment-1: evidence for three states of the thin filament."
  160. (1998). Regulatory properties of the NH2- and COOH-terminal domains of troponin T. ATPase activation and binding to troponin I and troponin C."
  161. (2001). Regulatory properties of tropomyosin effects of length, isoform, and N-terminal sequence."
  162. (1996). Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies."
  163. (2007). Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype."
  164. (1998). Role of myosin heavy chain composition in kinetics of force development and relaxation in rat myocardium."
  165. (2008). Role of the acidic N' region of cardiac troponin I in regulating myocardial function."
  166. (1999). Roles for the troponin tail domain in thin filament assembly and regulation. A deletional study of cardiac troponin T."
  167. (2008). Sarcomeric proteins and inherited cardiomyopathies."
  168. (1995). Separation and characterization of the two functional regions of troponin involved in muscle thin filament regulation."
  169. (1975). Separation of subfragment-1 isoenzymes from rabbit skeletal muscle myosin."
  170. (2004). Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy."
  171. (2010). Solution structure of the regulatory domain of human cardiac troponin C in complex with the switch region of cardiac troponin I and W7: the basis of W7 as an inhibitor of cardiac muscle contraction."
  172. (1999). Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene."
  173. (2004). Structural based insights into the role of troponin in cardiac muscle pathophysiology."
  174. (2008). Structural basis for tropomyosin overlap in thin (actin) filaments and the generation of a molecular swivel by troponin-T."
  175. (1997). Structure of cardiac muscle troponin C unexpectedly reveals a closed regulatory domain."
  176. (2003). Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form."
  177. Structures of four Ca2+-bound troponin C at 2.0 A resolution: further insights into the Ca2+-switch in the calmodulin superfamily."
  178. (1997). Sudden death due to troponin T mutations."
  179. (1989). Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk."
  180. (1980). Sudden death in young athletes."
  181. (2006). Synchrotron radiation circular dichroism spectroscopy of proteins and applications in structural and functional genomics."
  182. (1958). The contraction of muscle."
  183. (2002). The crystal structure of the C-terminal fragment of striatedmuscle alpha-tropomyosin reveals a key troponin T recognition site."
  184. (2001). The crystal structure of uncomplexed actin in the ADP state."
  185. (2002). The failing heart."
  186. (1992). The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy."
  187. (2001). The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms."
  188. (2006). The mechanism of smooth muscle caldesmon-tropomyosin inhibition of the elementary steps of the actomyosin ATPase."
  189. (1994). The molecular mechanism of muscle contraction: 40 years after the sliding filament hypothesis. Christ's College,
  190. (1998). The muscle thin filament as a classical cooperative/allosteric regulatory system."
  191. (2008). The Myosin Family: Biochemical and kinetic properties.” In Myosins: a superfamily of molecular motors
  192. (1971). The regulation of rabbit skeletal muscle contraction."
  193. (1961). The role of calcium in the superprecipitation of actomyosin."
  194. (1995). The troponin complex and regulation of muscle contraction."
  195. (2002). The troponin tail domain promotes a conformational state of the thin filament that suppresses myosin activity."
  196. (2008). The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxation."
  197. (1985). The use of actin labelled with N-(1-pyrenyl)iodoacamide to study the interaction of actin with myosin subfragments and troponin/tropomyosin."
  198. (1980). Theoretical model for the cooperative equilibrium binding of myosin subfragment 1 to the actin-troponintropomyosin complex."
  199. (1981). Theoretical models for cooperative steady-state ATPase activity of myosin subfragment-1 on regulated actin."
  200. (1996). Thin filament-mediated regulation of cardiac contraction."
  201. (1993). Three-dimensional structure of myosin subfragment-1: a molecular motor."
  202. (1994). Tikunov and L.Faust.
  203. Tikunova (2008). "Ca(2+) exchange with troponin C and cardiac muscle dynamics."
  204. (2007). Translational medicine with a capital T, troponin T, that is."
  205. (2000). Tropomyosin and actin isoforms modulate the localization of tropomyosin strands on actin filaments."
  206. (2005). Tropomyosin isoforms: divining rods for actin cytoskeleton function."
  207. (2008). Troponin and cardiomyopathy."
  208. (1998). Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments."
  209. (1998). Troponin T: genetics, properties and function."
  210. (2008). Troponin: regulatory function and disorders."
  211. (2002). Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility."
  212. (1987). Two step ligand binding and cooperativity. A model to describe the cooperative binding of myosin subfragment 1 to regulated actin."

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.